Antibodies

59


Antibodies


CHAPTER CONTENTS











INTRODUCTION


Antibodies are globulin proteins (immunoglobulins [Ig]) that react specifically with the antigen that stimulated their production. They make up about 20% of the protein in blood plasma. Blood contains three types of globulins, alpha, beta, and gamma, based on their electrophoretic migration rate. Antibodies are gamma globulins. There are five classes of antibodies: IgG, IgM, IgA, IgD, and IgE. Antibodies are subdivided into these five classes based on differences in their heavy chains.


The most important functions of antibodies are to neutralize toxins and viruses, to opsonize microbes so they are more easily phagocytosed, to activate complement, and to prevent the attachment of microbes to mucosal surfaces. The specific antibody classes that mediate these functions are described in Table 59–1. In addition to these functions, antibodies have a catalytic (enzymatic) capability that is described in a separate section at the end of this chapter.



TABLE 59–1 Properties of Human Immunoglobulins


image


MONOCLONAL ANTIBODIES


Antibodies that arise in an animal in response to typical antigens are heterogeneous, because they are formed by several different clones of plasma cells (i.e., they are polyclonal). Antibodies that arise from a single clone of cells (e.g., in a plasma cell tumor [myeloma])1 are homogeneous (i.e., they are monoclonal).


Monoclonal antibodies also can be made in the laboratory by fusing a myeloma cell with an antibody-producing cell (Figure 59–1; also see box “Hybridomas & Monoclonal Antibodies”). Such hybridomas produce virtually unlimited quantities of monoclonal antibodies that are useful in diagnostic tests and in research (see box “Hybridomas & Monoclonal Antibodies”).



image


FIGURE 59–1 Production of monoclonal antibodies.


IMMUNOGLOBULIN STRUCTURE


Immunoglobulins are glycoproteins made up of light (L) and heavy (H) polypeptide chains. The terms light and heavy refer to molecular weight; light chains have a molecular weight of about 25,000, whereas heavy chains have a molecular weight of 50,000 to 70,000. The simplest antibody molecule has a Y shape (Figure 59–2) and consists of four polypeptide chains: two H chains and two L chains. The four chains are linked by disulfide bonds. An individual antibody molecule always consists of identical H chains and identical L chains. This is primarily the result of two phenomena: allelic exclusion (see page 514) and regulation within the B cell, which ensure the synthesis of either kappa (κ) or lambda (λ) L chains, but not both.



image


FIGURE 59–2 Structure of immunoglobulin G (IgG). The Y-shaped IgG molecule consists of two light chains and two heavy chains. Each light chain consists of a variable region and a constant region. Each heavy chain consists of a variable region and a constant region that is divided into three domains: CH1, CH2, and CH3. The CH2 domain contains the complement-binding site, and the CH3 domain is the site of attachment of IgG to receptors on neutrophils and macrophages. The antigen-binding site is formed by the variable regions of both the light and heavy chains. The specificity of the antigen-binding site is a function of the amino acid sequence of the hypervariable regions (see Figure 59–3). (Modified and reproduced with permission from Brooks GF et al. Medical Microbiology. 20th ed. Originally published by Appleton & Lange. Copyright 1995 McGraw-Hill.)


L and H chains are subdivided into variable and constant regions. The regions are composed of three-dimensionally folded, repeating segments called domains. An L chain consists of one variable (VL) and one constant (CL) domain. Most H chains consist of one variable (VH) and three constant (CH) domains. (IgG and IgA have three CH domains, whereas IgM and IgE have four.) Each domain is approximately 110 amino acids long. The variable regions of both the light and heavy chain are responsible for antigen-binding, whereas the constant region of the heavy chain is responsible for various biologic functions (e.g., complement activation and binding to cell surface receptors). The complement binding site is in the CH2 domain. The constant region of the light chain has no known biologic function.


HYBRIDOMAS & MONOCLONAL ANTIBODIE







Hybridoma cells have the remarkable ability to produce large quantities of a single molecular species of immunoglobulin. These immunoglobulins, which are known as monoclonal antibodies, are called “monoclonal” because they are made by a clone of cells that arose from a single cell. Note, however, that this single cell is, in fact, formed by the fusion of two different cells (i.e., it is a hybrid), hence the term hybridoma. Hybridoma cells are made in the following manner: (1) An animal (e.g., a mouse) is immunized with the antigen of interest. (2) Spleen cells from this animal are grown in a culture dish in the presence of mouse myeloma cells. The myeloma cells have two important attributes: They grow indefinitely in culture, and they do not produce immunoglobulins. (3) Fusion of the cells is encouraged by adding certain chemicals (e.g., polyethylene glycol). (4) The cells are grown in a special culture medium (HAT medium) that supports the growth of the fused, hybrid cells but not of the “parental” cells. (5) The resulting clones of cells are screened for the production of antibody to the antigen of interest.


Chimeric monoclonal antibodies consisting of mouse variable regions and human constant regions are being made for use in treating human diseases such as leukemia. The advantages of the human constant chain are that human complement is activated (whereas it is not if the constant region is mouse-derived) and that antibodies against the monoclonal antibody are not formed (whereas antibodies are formed if the constant region is mouse-derived). The advantage of the mouse variable region is that it is much easier to obtain monoclonal antibodies against, for example, a human tumor antigen by inoculating a mouse with the tumor cells. Chimeric antibodies can kill tumor cells either by complement-mediated cytotoxicity or by delivering toxins (e.g., diphtheria toxin) specifically to the tumor cell.


Monoclonal antibodies are now used in a variety of clinical situations, such as immunosuppression related to organ transplants, treatment of autoimmune disease, treatment of cancer, and the prevention of infectious disease. Table 62–2 describes these monoclonal antibodies, their cellular targets, and their clinical use.






The variable regions of both L and H chains have three extremely variable (hypervariable) amino acid sequences at the amino-terminal end that form the antigen-binding site (Figure 59–3). Only 5 to 10 amino acids in each hypervariable region form the antigen-binding site. Antigen–antibody binding involves electrostatic and van der Waals’ forces and hydrogen and hydrophobic bonds rather than covalent bonds. The remarkable specificity of antibodies is due to these hypervariable regions (see the discussion of idiotypes on page 512).



image


FIGURE 59–3 The antigen-binding site is formed by the hypervariable regions. A: Hypervariable regions on immunoglobulin G (IgG). B: Magnified view of antigen-binding site. (Modified and reproduced with permission from Stites DP, Terr A, Parslow T, eds. Basic & Clinical Immunology. 8th ed. Originally published by Appleton & Lange. Copyright 1994 McGraw-Hill.)


L chains belong to one of two types, κ (kappa) or λ (lambda), on the basis of amino acid differences in their constant regions. Both types occur in all classes of immunoglobulins (IgG, IgM, etc.), but any one immunoglobulin molecule contains only one type of L chain.2


The amino-terminal portion of each L chain participates in the antigen-binding site. H chains are distinct for each of the five immunoglobulin classes and are designated γ, α, μ, ε, and δ (Table 59–2). The amino-terminal portion of each H chain participates in the antigen-binding site; the carboxy terminal forms the Fc fragment, which has the biologic activities described earlier and in Table 59–2.



TABLE 59–2 Important Functions of Immunoglobulins


image

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 26, 2017 | Posted by in MICROBIOLOGY | Comments Off on Antibodies

Full access? Get Clinical Tree

Get Clinical Tree app for offline access